FDA floats new rules for testing Alzheimer’s drugs – Science Magazine

February 16, 2018 by  
Filed under Alzheimers News

Sponsored By

Science Magazine
FDA floats new rules for testing Alzheimer's drugs
Science Magazine
For years now the gold standard for R&D in Alzheimer's disease has focused on generating convincing evidence that any new therapy being studied could slow the cognitive decline of patients and help preserve their ability to perform the kind of daily
The FDA raises hopes for Alzheimer's drugs with a new set of draft rules. But are they going too far?Endpoints News
FDA pushes pharma to continue efforts in Alzheimer'sBioPharma Dive
FDA Sets the Stage for Earlier-Stage Alzheimer's TreatmentsNasdaq
Indianapolis Business Journal -STAT
all 8 news articles »

More Info: Click here

Speak Your Mind

Tell us what you're thinking...
and oh, if you want a pic to show with your comment, go get a gravatar!

*